Ascelia develops and commercializes novel medicinal products for the treatment of cancer.
Business Model:
Revenue: $2
Employees: 2-10
Address: S.t Johannesgatan 2
City: Malmö
State: other
Zip: 211 46
Country: SE
Ascelia develops and commercializes novel medicinal products for the treatment of cancer.
Contact Phone:
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
3/15/2019
Ticker Symbol:
ACE
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 5/2018 | Unattributed | $6.9M | 3/2021 | Post-IPO Equity | $0 |
Svenska Handelsbanken Fourth Swedish National Pension Fund Healthinvest Partners Oresund Healthcare Management Sunstone Life Science Ventures Svenska Handelsbanken Fourth Swedish National Pension Fund Healthinvest Partners Oresund Healthcare Management Sunstone Life Science Ventures |
3/2019 | IPO | - | 3/2019 | IPO | - |
|
3/2021 | Post-IPO Equity | 5 | $23.7M |
Fourth Swedish National Pension Fund Healthinvest Partners Oresund Healthcare Management Sunstone Life Science Ventures Svenska Handelsbanken Fourth Swedish National Pension Fund Healthinvest Partners Oresund Healthcare Management Sunstone Life Science Ventures Svenska Handelsbanken |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|